Pixelgen Technologies
Pixelgen Technologies is a Stockholm-based life sciences company developing Proximity Network Assay and Molecular Pixelation kits for spatial proteomics analysis of single immune cells. It serves academic researchers and biopharmaceutical firms in immunology, oncology, hematology, and cell therapy through direct sales and global distribution partners.
- Company typePrivate
- Founded2020
- HeadquartersStockholm, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Pixelgen Technologies does
Pixelgen Technologies AB is a Stockholm-based, venture-backed life sciences tools company founded in 2020 that develops and sells spatial proteomics kits for analyzing cell surface protein organization on single immune cells. Its core technologies are the patented Proximity Network Assay (PNA) and the earlier Molecular Pixelation (MPX) platform, which use DNA-barcoded antibodies, rolling circle amplification, proximity oligos, and gap-fill ligation to build protein proximity networks that are read out on standard next-generation sequencing instruments (Illumina, MGI, Roche, Ultima, AVITI) without specialist imaging hardware. The flagship product is the Proxiome Kit v2 (Immuno 155 v2), a sample-prep consumable covering 155 cell surface proteins at ~50 nm resolution, with add-on modules for custom antibody conjugation and detection of engineered CAR T cells. An open-source analysis suite (pixelator Python CLI, pixelatorR R package, pixelatorES, nf-core/pixelator Nextflow pipeline) integrates with Scanpy, Seurat, Nextflow, Docker, Singularity, and Conda. Pixelgen monetizes primarily through one-time kit and reagent sales, quote-based pricing with volume tiers, and a US service-provider channel via Carolina Molecular. Customers are academic and translational researchers in immunology, immuno-oncology, hematology, and cell therapy, plus biopharma drug discovery teams; distribution is direct in the US and Europe, and via non-exclusive partners (BioStream, Australian Biosearch, MDxK) across APAC.
Pixelgen Technologies firmographics
Firmographics- Name
- Pixelgen Technologies
- Legal name
- Pixelgen Technologies AB
- Website
- https://www.pixelgen.com/
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pixelgen Technologies is a Stockholm-based life sciences company developing Proximity Network Assay and Molecular Pixelation kits for spatial proteomics analysis of single immune cells. It serves academic researchers and biopharmaceutical firms in immunology, oncology, hematology, and cell therapy through direct sales and global distribution partners.
- Ownership category
- akta.pro rank
Pixelgen Technologies industry classification
Industry- Product category
- Spatial Proteomics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
- akta.pro secondary industries
- Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling) (HLAAAMAK), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Pixelgen Technologies is headquartered
LocationHeadquarters
- HQ city
- Stockholm
- HQ country
- Sweden
- HQ region
- Europe
Offices1 record
Markets served
Pixelgen Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Spatial Proteomics Kits and Reagents: Pixelgen generates revenue primarily through the sale of its Proxiome Kit product line, including the Proxiome Kit v2 (Immuno 155), Custom Conjugation Kit, and CAR T detection products. These are consumable sample prep kits sold in configurable reaction formats (8, 16, 32 reactions). The company also offers volume-based pricing discounts for larger kit configurations.
- Service Provider Network Revenue: Through certified service providers (e.g., Carolina Molecular in the US), Pixelgen enables third-party labs to run its assays on behalf of end customers who lack in-house capabilities. This extends the commercial reach of the product without requiring direct sales to every end user.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Proxiome Kit v2, Immuno 155 v2 — 8 reactions |
| Unit Pricing | Pay-as-you-go | Proxiome Kit v2, Immuno 155 v2 — 16 reactions |
| Unit Pricing | Pay-as-you-go | Proxiome Kit v2, Immuno 155 v2 — 32 reactions |
| Unit Pricing | Pay-as-you-go | Proxiome v2 Custom Conjugation Kit — 2x Mouse IgG1 |
| Unit Pricing | Pay-as-you-go | Proxiome v2 Custom Conjugation Kit — 2x other host/subclass |
| Unit Pricing | Pay-as-you-go | Proxiome v2 Custom Conjugation Kit — 1x Mouse IgG1 + 1x other |
| Unit Pricing | Pay-as-you-go | Proxiome CAR-T Barcoded Antibodies (FMC63, FLAG, G4S) |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
Pixelgen Technologies product offering
Product offeringCore offering
Pixelgen Technologies develops and sells the Proximity Network Assay (PNA)-powered Proxiome Kit, a sample-preparation reagent kit that uses DNA-barcoded antibodies, rolling circle amplification, and next-generation sequencing to map protein abundance, clustering, and colocalization on the surface of single immune cells at nanoscale (~50nm) resolution. The offering includes complementary modules (Custom Conjugation Kit for user-defined antibodies, CAR T barcoded spike-in antibodies), along with an open-source software suite (pixelator, pixelatorR, nf-core/pixelator, pixelatorES) for data processing and analysis on standard NGS platforms.
Product overview
Pixelgen Technologies offers a platform-plus-modules architecture centered on spatial proteomics technology for single-cell analysis. The core Proxiome Kit v2 (Immuno 155) provides high-dimensional cell surface architecture analysis with 155 protein targets, which can be extended via the Custom Conjugation Kit (for custom antibody targets) and CAR T Antibodies (for CAR detection). The technology is powered by either the first-generation Molecular Pixelation (MPX) or second-generation Proximity Network Assay (PNA) platforms. Data analysis is enabled through a software suite including pixelator (Python CLI), pixelatorR (R package), pixelatorES (R reporting), and nf-core/pixelator (Nextflow pipeline), all integrated with standard bioinformatics tools like Scanpy, Seurat, and Nextflow for reproducible workflows on Illumina, MGI, Roche, Ultima Genomics, and AVITI sequencing platforms.
Differentiator
Problem solved
Functional benefit
Products and services
- Pixelgen Proxiome Kit v2 (Immuno 155 v2) High-dimensional analysis kit for cell surface architecture in single human immune cells, generating readouts on protein abundance, protein clustering, and protein colocalization for 155 surface proteins at nanoscale (~50nm) resolution. Supports up to 64 samples per experiment and ~1,000 single cells per sample. Runs on standard NGS platforms without specialized imaging hardware.
- Pixelgen Proxiome v2 Custom Conjugation Kit Add-on kit enabling integration of user-defined monoclonal antibodies into the Proxiome Kit v2 workflow, allowing tailored analysis of additional cell surface targets together with high-dimensional profiling of cell surface architecture. Supports up to two custom antibodies per experiment across three configurations.
- Pixelgen Proxiome CAR T Barcoded Antibodies (FMC63, FLAG, G4S) Barcoded antibody spike-ins for the Proxiome Immuno 155 panel enabling CAR detection and spatial profiling of engineered CAR T cells within clinical samples. Includes anti-FLAG (PP103), anti-FMC63 (PP102), and anti-G4S (PP104) reagents.
- pixelator Open-source Python software library and CLI tool providing methods and algorithms for processing, analysis, and visualization of 3D protein interactomics data from MPX and PNA assays. Converts raw FASTQ sequencing data into PXL files ready for downstream analysis.
- pixelatorR Open-source R software library for processing, analyzing, and visualizing Proximity Network assay (PNA) and Molecular Pixelation (MPX) single-cell data. Extends the Seurat toolbox with specialized S4 classes for spatial proteomics data structures.
- nf-core/pixelator Nextflow-based analysis pipeline for processing Proximity Network assay data. Part of the nf-core community project, enabling reproducible workflow execution on HPC clusters, cloud platforms, and local computing clusters.
- pixelatorES R package that generates Proxiome Summary Reports for multi-sample experiments, providing quick look at QC metrics, statistics, and visualizations. Automatically generated when running nf-core/pixelator v2.1+ with Proxiome Network Assay data.
Quantifiable outcome
- 3.7-fold increase in signal-to-noise ratio and 2.2x more data per cell with MPX v2 compared to v1
- +4 more outcomes
Companies that use Pixelgen Technologies
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
Pixelgen Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
Feature6 records
Pixelgen Technologies partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, significant and minor.
- Karolinska Institutet (Andreas Lundqvist Research Group)coreResearch collaboration to discover novel biomarkers for cancer immunotherapy response. Prof. Andreas Lundqvist's group will use Pixelgen's Proximity Network Assay to analyze the spatial distribution of over 150 cell surface proteins in non-small cell lung cancer patients undergoing immunotherapy. Results will be submitted for peer-reviewed publication and lay groundwork for future collaborations.
- MDxK / Molecular Diagnostics Korea (South Korea)significantDistribution agreement for South Korea signed December 2025. MDxK distributes Pixelgen's Proxiome Kit in South Korea to support research advancements in immunology and cancer. This partnership further expands Pixelgen's distribution network in Asia following agreements with BioStream (Japan) and Australian Biosearch (ANZ).
- Dr. Aaron D. Viny (Columbia University)minorDr. Aaron Viny, internationally recognized physician-scientist at Columbia University Irving Medical Center, was appointed to Pixelgen's Scientific Advisory Board in November 2025. He focuses on clonal hematopoiesis, MDS, and AML. His research into 3D DNA architecture in blood cancers is expected to help advance Pixelgen's applications in blood diseases and cancer.
- Carolina Molecular Inc.coreCarolina Molecular became the first US certified service provider for Pixelgen's Proxiome Kit in November 2025. Provides academic, pharmaceutical, and biotech researchers across the US with access to Pixelgen's Proximity Network Assay for protein interactomics analysis. Leverages Carolina Molecular's NGS Foundry and bioinformatics capabilities for data delivery.
- Mostafa Ronaghi (Cellanome / Former Illumina CTO)minorRenowned genomicist and serial entrepreneur appointed to Pixelgen's Scientific Advisory Board in April 2024. Previously served as CTO and SVP of entrepreneurial development at Illumina. Co-founded GRAIL and multiple successful life sciences companies. Brings deep expertise in genomics and entrepreneurial development to guide Pixelgen's commercial expansion.
- Australian BiosearchsignificantNon-exclusive distribution agreement for Australia and New Zealand signed February 2024. Australian Biosearch brings Pixelgen's Molecular Pixelation kits to the ANZ region to meet growing customer demand. Australian Biosearch is well regarded for bringing innovative tools to industry and academia.
- BioStream Co. Ltd (Japan)significantNon-exclusive distribution agreement for Japan signed February 2024. BioStream distributes Pixelgen's spatial proteomics kits to bioresearch institutions and companies in Japan. BioStream is a well-established distributor in Japan with many years of experience serving pharmaceutical and biotech companies.
Scale indicators9 records
Recent moves9 records
Expansion highlights7 records
Pixelgen Technologies competitors and assessment
Company assessmentDirect peers
- 10x Genomics: Leading single-cell and spatial biology platform whose Xenium (in situ) and Visium products compete with Pixelgen in spatial omics for single cells. Several Pixelgen executives (Alvaro Martinez Barrio, Annika Branting, Brad Crutchfield, Tarjei Mikkelsen) are 10x alumni, and the platforms target overlapping academic and pharma customers.
- NanoString Technologies: Spatial biology competitor with CosMx SMI (single-molecule imaging) and GeoMx digital spatial profiling, directly addressing the same translational research and immuno-oncology customer base that Pixelgen's Proxiome Kit targets.
- Akoya Biosciences: Spatial proteomics company offering PhenoCycler (single-cell) and PhenoImager (tissue) platforms that compete in immuno-oncology and tumor microenvironment applications highly overlapping with Pixelgen's CAR-T and immune-cell surface biology focus.
Broad incumbents
- Olink: Proteomics tools company commercializing the Proximity Extension Assay—founded by Pixelgen CEO Simon Fredriksson. Operates a much broader installed base across pharma and academic proteomics; relevant as a precedent for scaling multiplex proteomics and a likely customer-overlap competitor.
- Standard BioTools (formerly Fluidigm): Provider of mass cytometry and imaging mass cytometry instruments for single-cell proteomics, serving similar immunology and translational research customers with established imaging-based workflows that Pixelgen's optics-free approach seeks to complement or substitute.
- Bio-Techne: Diversified life sciences tools company with proteomics reagents (ProteinSimple, R&D Systems) and spatial biology offerings. Provides a comparable consumables-and-instruments franchise across the same academic and biopharma proteomics buyers.
- AbCellera Biologics: Antibody discovery and immune profiling platform with single-cell B-cell sequencing capabilities relevant to immune cell characterization; competes for immuno-oncology and cell-therapy customer budget adjacent to Pixelgen's CAR-T and surface-proteomics applications.
- Bruker: Analytical instruments manufacturer with mass spectrometry and spatial proteomics/imaging mass cytometry solutions (e.g., timsTOF, CellScape). Overlaps with Pixelgen in translational proteomics customers and in serving immunology, hematology, and pharma research labs.
- Becton, Dickinson and Company (BD): Major life sciences and diagnostics company with flow cytometry, single-cell multiomics (BD CellView, FACSDiscover), and cell therapy manufacturing tools. Competes for immunology and cell-therapy characterization budget that Pixelgen also targets with its Proxiome CAR-T products.
Emerging players
- IsoPlexis (now part of Berkley Lights' successor entities / acquired): Single-cell functional proteomics platform targeting cell therapy and immuno-oncology characterization—directly comparable to Pixelgen's CAR-T and immune cell-surface profiling use cases in translational and clinical research.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Pixelgen Technologies social profiles
Digital presencePixelgen Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pixelgen Technologies leadership team
Management profileNumber of profiles
Profiles17 records
Pixelgen Technologies funding detail
Funding detailFunding overview
Funding rounds5 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pixelgen Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pixelgen Technologies
What does Pixelgen Technologies do?
Pixelgen Technologies develops and sells the Proximity Network Assay (PNA)-powered Proxiome Kit, a sample-preparation reagent kit that uses DNA-barcoded antibodies, rolling circle amplification, and next-generation sequencing to map protein abundance, clustering, and colocalization on the surface of single immune cells at nanoscale (~50nm) resolution. The offering includes complementary modules (Custom Conjugation Kit for user-defined antibodies, CAR T barcoded spike-in antibodies), along with an open-source software suite (pixelator, pixelatorR, nf-core/pixelator, pixelatorES) for data processing and analysis on standard NGS platforms.
Is Pixelgen Technologies a public or private company?
Pixelgen Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was Pixelgen Technologies founded?
Pixelgen Technologies was founded in 2020. It employs 11 to 50 people.
Where is Pixelgen Technologies based?
Pixelgen Technologies is headquartered in Stockholm, Sweden, in the Europe region.
How does Pixelgen Technologies make money?
Two revenue lines are on record. Spatial Proteomics Kits and Reagents are the primary driver. The others are service Provider Network Revenue.
Who are Pixelgen Technologies's main competitors?
Direct peers on record are 10x Genomics, NanoString Technologies and Akoya Biosciences. Broad incumbents are Olink, Standard BioTools (formerly Fluidigm), Bio-Techne, AbCellera Biologics, Bruker and Becton, Dickinson and Company (BD). IsoPlexis (now part of Berkley Lights' successor entities / acquired) is listed as an emerging player.
Does Pixelgen Technologies have an API?
No public API is recorded for Pixelgen Technologies.
What industry is Pixelgen Technologies in?
Pixelgen Technologies's product category is Spatial Proteomics. Its primary akta.pro industry code is HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays), with a secondary code of HLAAAMAK, Immuno-Oncology & Immune Monitoring Biomarkers (TMB, MSI, MRD, immune profiling). Its NAICS code is 325413 and its SIC code is 2835.